Laval-based pharmaceutical company Bausch + Lomb plans US$788-million IPO

latest news headlines 3 months ago
Pharmaceutical company Bausch Health Companies Inc. BHC-T is finalizing the sale of a stake in eye-care division Bausch + Lomb Corp. through a US$788-million initial public offering, taking a major step toward unwinding past management’s acquisition spree. This week, the Laval, Que.-based company is …
Read Entire Article